Polymorphonuclear leukocytes have been shown to use a multitude of effector functions to combat pathogens and tumors, including enzymes, defensins, and toxic products such as oxygen radicals and nitrogen oxides. Recent studies provided evidence for the expression of granzymes (gzms) and perforin (perf) within the cytotoxic arsenal of human neutrophils, the validity of which was questioned by 2 subsequent studies. We have now used cytology, intracellular flow cytometry, enzymatic assays, immunoelectron microscopy, and quantitative reverse transcriptase-polymerase chain reaction to obtain evidence of the presence of gzms and/or perf in mouse Gr-1 ؉ granulocyte populations. The data obtained clearly demonstrate that neither in vitronor in vivo-derived mouse granulocytes synthesize gzmA and gzmB or perf, even following infection/immunization with pathogens or pathogen-derived material. A parallel comparable analysis on the expression of gzmB in human neutrophils from 3 healthy control subjects and 4 patients with diverse diseases failed to detect gzmB expression. The data indicate that polymorphonuclear leukocytes from mice and humans lack the 3 cytotoxic effector molecules, gzmA, gzmB, and perf, generally associated with natural killer and cytotoxic T lymphocytes.
IntroductionPerforin (perf) and granzymes (gzms) are major components of cytoplasmic granules from natural killer (NK) cells and cytotoxic T lymphocytes (CTLs) and are critical cytolytic effector molecules in NK/CTL-mediated apoptosis and are required for the control of intracellular pathogens and tumors. [1][2][3][4][5][6][7][8][9][10] In mice and humans, gzms, in particular gzmA and gzmB, and perf are produced mainly by the majority of NK cells and CTLs, a fraction of CD4 ϩ T cells, [11][12][13] and to a lesser extent by related cell types, such as metrial gland cells, 14 but not by polymorphonuclear leukocytes (granulocytes/neutrophils) and monocytes. [15][16][17] Two recent studies provided evidence that gzms and perf are also produced by human polymorphonuclear neutrophils (PMNs). 18,19 These reports were intriguing in light of the known biologic effects of gzms and perf in NK/CTL-mediated immune responses 8,10,20,21 and the role of PMNs as a first-line defense against microbial pathogens 22,23 and tumors. 24,25 However, the assumption that PMNs use the same set of molecules as NK/CTL to combat pathogens and tumors was challenged by 2 subsequent studies. 26,27 To date, the discrepancy of the 4 studies, which used similar techniques for the enrichment of PMNs and to analyze the expression of GZM-and PRF1-specific transcripts and/or proteins, has not been resolved.We have now analyzed in detail the expression of gzmA, gzmB, and perf in in vitro-generated and ex vivo-derived mouse granulocytes by combining cytology, correlative cell surface phenotypic analysis, intracellular flow cytometry, enzyme assays, immunoelectron microscopy (IEM), and reverse transcriptase-polymerase chain reaction (RT-PCR) analysis. In addition we have investigated the expressi...